Yunzhi Liu Selected Research

Mannose-Binding Protein Deficiency

1/2022	Mannan-Binding Lectin Deficiency Limits Inflammation-induced Myeloid-Derived Suppressor Cells Expansion via Modulating Tumor Necrosis Factor Alpha-triggered Apoptosis.
12/2021	Mannan-binding lectin deficiency augments hepatic endoplasmic reticulum stress through IP3R-controlled calcium release.
1/2019	Mannan-binding lectin deficiency exacerbates sterile liver injury in mice through enhancing hepatic neutrophil recruitment.
1/2019	Mannan-binding lectin attenuates acetaminophen-induced hepatotoxicity by regulating CYP2E1 expression via ROS-dependent JNK/SP1 pathway.
1/2019	Mannan-binding lectin suppresses growth of hepatocellular carcinoma by regulating hepatic stellate cell activation via the ERK/COX-2/PGE2 pathway.
1/2019	Mannan-binding lectin promotes keratinocyte to produce CXCL1 and enhances neutrophil infiltration at the early stages of psoriasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yunzhi Liu Research Topics

Disease

6	Mannose-Binding Protein Deficiency 01/2022 - 01/2019
5	Infections 01/2020 - 01/2014
4	Inflammation (Inflammations) 01/2022 - 01/2018
3	Arthritis (Polyarthritis) 01/2022 - 01/2019
2	Necrosis 12/2021 - 01/2019
2	Acute Liver Failure (Fulminant Hepatic Failure) 10/2021 - 01/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2020
2	Chemical and Drug Induced Liver Injury 01/2020 - 01/2019
2	Neoplasms (Cancer) 01/2019 - 01/2013
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2022
1	Hepatitis 12/2021
1	Hypersensitivity (Allergy) 12/2021
1	Liver Diseases (Liver Disease) 12/2021
1	Fibrosis (Cirrhosis) 10/2021
1	Fatty Liver 10/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Ischemic Stroke 01/2021
1	Liver Failure 01/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Atopic Dermatitis (Atopic Eczema) 01/2018
1	Massive Hepatic Necrosis 01/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2013

Drug/Important Bio-Agent (IBA)

5	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 06/2022 - 01/2019
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2021 - 01/2020
2	CalciumIBA 06/2022 - 12/2021
2	Freund's AdjuvantIBA 01/2022 - 12/2021
2	Alanine Transaminase (SGPT)IBA 12/2021 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2019
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020 - 01/2019
2	Scavenger Receptors (Scavenger Receptor)IBA 01/2020 - 01/2018
1	indium-bleomycinIBA 06/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	incomplete Freund's adjuvantIBA 01/2022
1	CytokinesIBA 12/2021
1	Concanavalin AIBA 12/2021
1	Inositol (Myoinositol)IBA 12/2021
1	Phosphotransferases (Kinase)IBA 12/2021
1	LeptinIBA 12/2021
1	Transcription Factor CHOPIBA 12/2021
1	AdipokinesIBA 12/2021
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021
1	TEMPOIBA 01/2021
1	AntioxidantsIBA 01/2021
1	Interferon Type IIBA 01/2020
1	InterferonsIBA 01/2020
1	TNF Receptor-Associated Factor 3IBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Chemokine CXCL2IBA 01/2019
1	Imiquimod (Aldara)FDA LinkGeneric 01/2019
1	LectinsIBA 01/2019
1	collagen type I trimeric cross-linked peptideIBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019
1	Procollagen Type IIBA 01/2019
1	Dinoprostone (PGE2)FDA Link 01/2019
1	Chemokine CXCL1IBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Thymic Stromal LymphopoietinIBA 01/2018
1	Toll-Like Receptor 4IBA 01/2018
1	HaptensIBA 01/2018
1	Dinitrochlorobenzene (DNCB)IBA 01/2018
1	AntibodiesIBA 01/2014
1	SurvivinIBA 01/2013

Therapy/Procedure

2	Subcutaneous Injections 01/2022 - 12/2021
1	General Anesthesia 01/2022
1	Intravenous Injections 12/2021
1	Therapeutics 12/2021